SPOTLIGHT: FDA tightens access to acne drug

Federal regulators are establishing a national registry for the thousands of Americans who take the acne drug Accutane and people who prescribe and dispense it. The registry is part of a major initiative to tighten access to the medicine, which causes birth defects. Story

Suggested Articles

Rachel Humphrey, M.D., who joined CytomX as chief medical officer after heading immuno-oncology at AstraZeneca and Eli Lilly, has made her exit.

Scientists have discovered a scorpion toxin could inspire treatments to block the inflammation that triggers chronic pain.

The phase 2 success keeps Hal Barron’s group on track to file for approval in multiple myeloma by the end of the year.